<ul data-eligibleForWebStory="false"><li>Sun Pharma and Incyte have reached a settlement in the Leqselvi lawsuit in the US.</li><li>This settlement includes mutual release of claims and a non-exclusive license for certain patents related to alopecia treatment.</li><li>Leqselvi, indicated for severe alopecia areata, has been launched in the US by Sun Pharma.</li><li>The drug showed promising results in trials, with one-third of patients regaining almost all hair by Week 24.</li></ul>

Sun Pharma, Incyte settle Leqselvi lawsuit; launches alopecia drug in US

Discover more